| Literature DB >> 33914267 |
Qing Xia1, XinYu Yang1, JiaBin Shi1, ZiJie Liu1, YaHui Peng1,2,3,4, WenJing Wang1, BoWen Li1, Yu Zhao1, JiaYing Xiao1, Lei Huang1, DaYong Wang5,6,7,8, Xu Gao9,10,11,12.
Abstract
Alzheimer's disease is a progressive neurodegenerative disorder characterized by extracellular amyloid beta peptides and neurofibrillary tangles consisted of intracellular hyperphosphorylated Tau in the hippocampus and cerebral cortex. Most of the mutations in key genes that code for amyloid precursor protein can lead to significant accumulation of these peptides in the brain and cause Alzheimer's disease. Moreover, some point mutations in amyloid precursor protein can cause familial Alzheimer's disease, such as Swedish mutation (KM670/671NL) and A673V mutation. However, recent studies have found that the A673T mutation in amyloid precursor protein gene can protect against Alzheimer's disease, even if it is located next to the Swedish mutation (KM670/671NL) and at the same site as A673V mutation, which are pathogenic. It makes us curious about the protective A673T mutation. Here, we summarize the most recent insights of A673T mutation, focus on their roles in protective mechanisms against Alzheimer's disease, and discuss their involvement in future treatment.Entities:
Keywords: A673T mutation; Aggregation; Alzheimer’s disease; Amyloid beta; Amyloid precursor protein; Treatment
Mesh:
Substances:
Year: 2021 PMID: 33914267 DOI: 10.1007/s12035-021-02385-y
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.590